Tirzepatide
The question
To ask the Secretary of State for Health and Social Care, what proportion of Mounjaro (a) prescribing and (b) medication management services his Department plans to carry out digitally.
Answered by Dr Zubir Ahmed
There are not currently any specific targets for the proportions of prescribing and medication management activity of tirzepatide, also known as Mounjaro, including monitoring, follow-up, and review for tirzepatide that will be carried out digitally.
The National Health Service is in the process of making tirzepatide available for weight management in primary care, including developing and testing new models of care, like community-based services and digital technologies. NHS England is working with the Office for Life Sciences and other partners to develop digitally enabled care pathways, supported by behavioural interventions, with patient safety and clinical oversight at their core. These innovative pathways are being designed to bring together remote prescribing, personalised behavioural support, and ongoing clinical supervision, allowing patients to access high-quality care in a way that is convenient and tailored to their individual needs.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →